Approval Letter GENENTECH (Mar 30, 2026)
FDA issued an approval letter for KADCYLA on 2026-03-30. The source metadata identifies BLA 125427 as a supplement. Review the exact FDA letter for the approved conditions and labeling.
FDA LETTER LIBRARY
Review 1,503 source-backed approval, tentative approval, complete response, and warning letters. Application letters cover 2026; the CRL corpus is complete as published by openFDA, and warning letters cover 2026.
Showing 1081-1092 of 1503 letters